yutiq
Generic: fluocinolone acetonide intravitreal implant·Brand: Yutiq
yutiq: sourced relationships with 2 companies · 1 FDA decision.
yutiq evidence translation
What we can confirm
1 FDA record
What it means
More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
What is verified about yutiq, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
treatment and prevention of chronic NIU-PSUveitis
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| ALIMERA SCIENCES INC (ALIM) treatment and prevention of chronic NIU-PS | Approved |
| ANI PHARMACEUTICALS INC (ANIP) Uveitis | Approved |
FDA Decisions1 records
Frequently asked questions
Which companies have sourced relationships with yutiq?
yutiq has dated SEC/FDA relationship records for ALIMERA SCIENCES INC, ANI PHARMACEUTICALS INC.
What is yutiq's latest FDA decision?
The most recent tracked FDA decision for yutiq is Approval, dated October 12, 2018.